The Standing Technical Sub-Committee (STSC) of NTAGI recommended the use of Biological E manufactured Corbevax and Bharat Biotech’s Covaxin for children aged between 5-12 years.
The Standing Technical Sub-Committee of NTAGI recommended the use of Biological E manufactured Corbevax and Bharat Biotech’s Covaxin for children (Photo: Representational)
The Standing Technical Sub-Committee (STSC) of NTAGI recommended the use of Biological E manufactured Corbevax and Bharat Biotech’s Covaxin for children aged between 5-12 years.
Corbevax has been recommended for children aged 5-12 years old, while Covaxin has been recommended for children in the 6 to 12 year age group.
On April 26, the Drugs Controller General of India (DCGI) granted Bharat Biotech the permission to use Covaxin for those aged 6 to 12 years. In April, the expert panel of Drug Controller General of India (DCGI)– India’s drug regulator– recommended granting emergency use authorisation for Biological E’s Covid-19 vaccine Corbevax for children in the 5 to 12 years age group.
— ENDS —